Regulation of blood coagulation by the protein C system

Protein G is a plasma, vitamin K‐dependent zymogen of a serine protease that can inhibit blood coagulation. Protein G is regulated by a series of reactions known as the protein G pathway. The importance of this pathway is seen in the occurrence of thrombosis in individuals with deficiencies in elements of the pathway like protein G and protein S. Work on several steps in this pathway has revealed that mechanisms involved in activation of protein G and the expression of its anticoagulant activity have features that allow for the expression of the anticoagulant activity away from sites in which procoagulant reactions occur, but not systemically. Thrombin, the principal procoagulant enzyme at the site of an injury, is converted to an anticoagulant enzyme at distant sites through its interaction with the endothelial cell protein thrombomodulin. Structural and functional studies have revealed the importance of several domain structures in the modulation of thrombin activity. Structural features of both activated protein C and its substrates (coagulation factors V and VIII) are such that they require the localization of enzyme and substrate on the surface of phosphtatidyl serine containing membranes for optimum activity.—Walker, F. J.; Fay, P. J. Regulation of blood coagulation by the protein C system. FASEB J. 6: 2561‐2567; 1992.

[1]  K. Mann,et al.  Isolation and characterization of single chain bovine factor V. , 1979, The Journal of biological chemistry.

[2]  C. Esmon.  The subunit structure of thrombin-activated factor V. Isolation of activated factor V, separation of subunits, and reconstitution of biological activity. , 1979, The Journal of biological chemistry.

[3]  C. Esmon,et al.  Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[4]  C. Esmon,et al.  Complex formation between thrombin and thrombomodulin inhibits both thrombin-catalyzed fibrin formation and factor V activation. , 1982, The Journal of biological chemistry.

[5]  K. Mann,et al.  Studies of the capacity of factor Xa to protect factor Va from inactivation by activated protein C. , 1982, The Journal of biological chemistry.

[6]  C. Esmon,et al.  Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C. , 1982, The Journal of biological chemistry.

[7]  B. Dahlbäck,et al.  Inactivation of human coagulation factor V by activated protein C. , 1983, The Journal of biological chemistry.

[8]  C. Esmon,et al.  Structural changes required for activation of protein C are induced by Ca2+ binding to a high affinity site that does not contain gamma-carboxyglutamic acid. , 1983, The Journal of biological chemistry.

[9]  C. Esmon,et al.  Proteolytic formation and properties of gamma-carboxyglutamic acid-domainless protein C. , 1983, The Journal of biological chemistry.

[10]  C. Esmon,et al.  Thrombomodulin blocks the ability of thrombin to activate platelets. , 1983, The Journal of biological chemistry.

[11]  C. Esmon,et al.  Loss of prothrombin and of factor Xa-factor Va interactions upon inactivation of factor Va by activated protein C. , 1984, The Journal of biological chemistry.

[12]  J. Griffin,et al.  Proteolytic inactivation of human factor VIII procoagulant protein by activated human protein C and its analogy with factor V. , 1984, Blood.

[13]  K. Mann,et al.  The binding of activated protein C to factors V and Va. , 1986, The Journal of biological chemistry.

[14]  D. Beeler,et al.  Characterization of a thrombomodulin cDNA reveals structural similarity to the low density lipoprotein receptor. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[15]  G. Vehar,et al.  Proteolytic processing of human factor VIII. Correlation of specific cleavages by thrombin, factor Xa, and activated protein C with activation and inactivation of factor VIII coagulant activity. , 1986, Biochemistry.

[16]  J. Hofsteenge,et al.  The effect of thrombomodulin on the cleavage of fibrinogen and fibrinogen fragments by thrombin. , 1987, European journal of biochemistry.

[17]  P. Fay,et al.  INACTIVATION OF FACTOR VIII BY ACTIVATED PROTEIN C AND PROTEIN S , 1987, Thrombosis and Haemostasis.

[18]  D. Beeler,et al.  Human thrombomodulin gene is intron depleted: nucleic acid sequences of the cDNA and gene predict protein structure and suggest sites of regulatory control. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[19]  L. Berliner,et al.  Ligands which effect human protein C activation by thrombin. , 1987, The Journal of biological chemistry.

[20]  K. Mann,et al.  Proteolysis of factor Va by factor Xa and activated protein C. , 1987, The Journal of biological chemistry.

[21]  J. Stenflo,et al.  Relationship between anticoagulant activities and polyanionic properties of rabbit thrombomodulin. , 1988, The Journal of biological chemistry.

[22]  C. Esmon,et al.  A 10-kDa cyanogen bromide fragment from the epidermal growth factor homology domain of rabbit thrombomodulin contains the primary thrombin binding site. , 1988, The Journal of biological chemistry.

[23]  W. Kane,et al.  Blood coagulation factors V and VIII: structural and functional similarities and their relationship to hemorrhagic and thrombotic disorders. , 1988, Blood.

[24]  R. Houghten,et al.  An immunogenic region within residues Val1670-Glu1684 of the factor VIII light chain induces antibodies which inhibit binding of factor VIII to von Willebrand factor. , 1988, The Journal of biological chemistry.

[25]  T. E. Petersen,et al.  The amino‐terminal domain of thrombomodulin and pancreatic stone protein are homologous with lectins , 1988, FEBS letters.

[26]  M. Tucker,et al.  Kinetics of inactivation of membrane-bound factor Va by activated protein C. Protein S modulates factor Xa protection. , 1988, The Journal of biological chemistry.

[27]  W. Schneider,et al.  beta-Hydroxyaspartic acid or beta-hydroxyasparagine in bovine low density lipoprotein receptor and in bovine thrombomodulin. , 1988, The Journal of biological chemistry.

[28]  L. Berliner,et al.  Evidence for multiple conformational changes in the active center of thrombin induced by complex formation with thrombomodulin: an analysis employing nitroxide spin-labels. , 1988, Biochemistry.

[29]  S. Yamamoto,et al.  A domain composed of epidermal growth factor-like structures of human thrombomodulin is essential for thrombin binding and for protein C activation. , 1989, The Journal of biological chemistry.

[30]  C. Esmon,et al.  Microthrombomodulin. Residues 310-486 from the epidermal growth factor precursor homology domain of thrombomodulin will accelerate protein C activation. , 1989, The Journal of biological chemistry.

[31]  P. Fay,et al.  Inactivation of human factor VIII by activated protein C: evidence that the factor VIII light chain contains the activated protein C binding site. , 1989, Biochimica et biophysica acta.

[32]  P. Lollar,et al.  Subunit structure of thrombin-activated porcine factor VIII. , 1989, Biochemistry.

[33]  S. Yamamoto,et al.  Further localization of binding sites for thrombin and protein C in human thrombomodulin. , 1990, The Journal of biological chemistry.

[34]  P. Fay,et al.  Identification of the binding site for activated protein C on the light chain of factors V and VIII. , 1990, The Journal of biological chemistry.

[35]  K. Hirahara,et al.  The effect of human thrombomodulin on the inactivation of thrombin by human antithrombin III. , 1990, Thrombosis research.

[36]  P. Lollar,et al.  pH-dependent denaturation of thrombin-activated porcine factor VIII. , 1990, The Journal of biological chemistry.

[37]  U. Lindahl,et al.  Isolation and characterization of the glycosaminoglycan component of rabbit thrombomodulin proteoglycan. , 1990, The Journal of biological chemistry.

[38]  P. Fay,et al.  Characterization of an interaction between protein C and ceruloplasmin. , 1990, The Journal of biological chemistry.

[39]  M. Rick,et al.  Factor IXa and von Willebrand factor modify the inactivation of factor VIII by activated protein C. , 1990, The Journal of laboratory and clinical medicine.

[40]  C. Vlahos,et al.  Stable expression of a secretable deletion mutant of recombinant human thrombomodulin in mammalian cells. , 1990, The Journal of biological chemistry.

[41]  R. Houghten,et al.  Synthetic factor VIII peptides with amino acid sequences contained within the C2 domain of factor VIII inhibit factor VIII binding to phosphatidylserine. , 1990, Blood.

[42]  J. Tschopp,et al.  Domain structure of the endothelial cell receptor thrombomodulin as deduced from modulation of its anticoagulant functions. Evidence for a glycosaminoglycan-dependent secondary binding site for thrombin. , 1990, The Journal of biological chemistry.

[43]  P. Fay,et al.  von Willebrand factor mediates protection of factor VIII from activated protein C-catalyzed inactivation. , 1991, The Journal of biological chemistry.

[44]  P. Fay,et al.  Activated protein C-catalyzed inactivation of human factor VIII and factor VIIIa. Identification of cleavage sites and correlation of proteolysis with cofactor activity. , 1991, The Journal of biological chemistry.